Cargando…

Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art

Background: Tuberculosis (TB) can seriously affect the hematopoietic system, with involvement of both myeloid and lymphoid cell lines as well as plasma components. These hematological changes act as a marker for the diagnosis, prognosis and response to therapy. Methods: We searched PubMed, Scopus, G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minardi, Maria Letizia, Fato, Ilenia, Di Gennaro, Francesco, Mosti, Silvia, Mastrobattista, Annelisa, Cerva, Carlotta, Libertone, Raffaella, Saracino, Annalisa, Goletti, Delia, Girardi, Enrico, Andreoni, Massimo, Palmieri, Fabrizio, Gualano, Gina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304680/ https://www.ncbi.nlm.nih.gov/pubmed/34361913 http://dx.doi.org/10.3390/microorganisms9071477

Ejemplares similares

Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Bari, Virginia, et al.
Publicado: (2022)

Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
por: Musso, Maria, et al.
Publicado: (2021)

Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2021)

Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review
por: Patti, Giulia, et al.
Publicado: (2021)

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report
por: Gualano, Gina, et al.
Publicado: (2020)

Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy
por: Gualano, Gina, et al.
Publicado: (2019)

Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
por: Musso, Maria, et al.
Publicado: (2019)

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

Active Pulmonary Tuberculosis in Elderly Patients: A 2016–2019 Retrospective Analysis from an Italian Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2020)

Antibiotics and Infectious Respiratory Diseases
por: Di Gennaro, Francesco, et al.
Publicado: (2022)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report
por: Guido, Giacomo, et al.
Publicado: (2023)

COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
por: García-García, José-María, et al.
Publicado: (2022)

Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report
por: Malagnino, Vincenzo, et al.
Publicado: (2019)

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
por: Grace, Patricia S., et al.
Publicado: (2021)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Benefits of Steroid Therapy in COVID-19 Patients with Different PaO(2)/FiO(2) Ratio at Admission
por: Vita, Serena, et al.
Publicado: (2021)

A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multicentric Study (2006–2008). Evaluation of QuantiFERON-TB Gold in Tube for TB Diagnosis
por: Lagrange, Philippe H., et al.
Publicado: (2013)

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
por: Petrone, Linda, et al.
Publicado: (2021)

Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children
por: Sali, Michela, et al.
Publicado: (2015)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
por: Aiello, Alessandra, et al.
Publicado: (2022)

A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB Diagnosis
por: Lagrange, Philippe H., et al.
Publicado: (2014)

Detection of Pulmonary tuberculosis: comparing MR imaging with HRCT
por: Busi Rizzi, Elisa, et al.
Publicado: (2011)

Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
por: Xia, Hui, et al.
Publicado: (2015)

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
por: Gualano, Gina, et al.
Publicado: (2016)

Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir
por: Campogiani, Laura, et al.
Publicado: (2019)

Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients
por: Papagni, Roberta, et al.
Publicado: (2022)

Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
por: Cornel, Annelisa M., et al.
Publicado: (2018)

Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes
por: Goletti, D., et al.
Publicado: (2023)

Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report
por: Foroghi Biland, Luca, et al.
Publicado: (2019)

Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients
por: Macchi, Beatrice, et al.
Publicado: (2020)

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
por: Mastrorosa, Ilaria, et al.
Publicado: (2023)

World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic
por: Petersen, Eskild, et al.
Publicado: (2022)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Genome-scale antibody responses in TB
por: Gennaro, Maria L
Publicado: (2010)

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4(+) and CD8(+) T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
por: Aiello, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7u3pp3op4g8oa7c6m108epkl2g